Pramlintide Acetate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Pramlintide Acetate Injection (injection) from AstraZeneca AB with status To Be Discontinued. The shortage was first posted on 10/27/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- AstraZeneca AB
- Package NDC
- 0310-6615-02
- Dosage Form
- Injection
- Presentation
- SymlinPen® 60 , Injection, 1000 ug/1 mL (NDC 0310-6615-02)
- Initial Posting
- 10/27/2025
- Revised Date